These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19871579)

  • 1. IMMUNITY IN MUMPS : VI. EXPERIMENTS ON THE VACCINATION OF HUMAN BEINGS WITH FORMOLIZED MUMPS VIRUS.
    Stokes J; Enders JF; Maris EP; Kane LW
    J Exp Med; 1946 Oct; 84(5):407-28. PubMed ID: 19871579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUMPS MENINGOENCEPHALITIS, TORONTO, 1963.
    MCLEAN DM; BACH RD; LARKE RP; MCNAUGHTON GA
    Can Med Assoc J; 1964 Feb; 90(7):458-62. PubMed ID: 14120950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of mumps disease is related to MMR vaccination status and viral shedding.
    Gouma S; Hahné SJ; Gijselaar DB; Koopmans MP; van Binnendijk RS
    Vaccine; 2016 Apr; 34(16):1868-73. PubMed ID: 26954106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute parotitis in children previously vaccinated against mumps].
    Mihály I; Budai J; Gerö A; Kukán E
    Orv Hetil; 1994 Feb; 135(6):287-90. PubMed ID: 8309684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMMUNITY IN MUMPS : I. EXPERIMENTS WITH MONKEYS (MACACUS MULATTA). THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY FOLLOWING INFECTION AND EXPERIMENTS ON IMMUNIZATION BY MEANS OF INACTIVATED VIRUS AND CONVALESCENT HUMAN SERUM.
    Enders JF; Kane LW; Cohen S; Levens JH
    J Exp Med; 1945 Jan; 81(1):93-117. PubMed ID: 19871448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunologic response of children to the injection of chick embryo propagated mumps virus vaccine as measured by the complement fixation test.
    CABASSO V; RUEGSEGGER JM; LOOSER GK; COX HR
    J Lab Clin Med; 1950 May; 35(5):771-9. PubMed ID: 15422210
    [No Abstract]   [Full Text] [Related]  

  • 7. IMMUNITY IN MUMPS : V. THE CORRELATION OF THE PRESENCE OF DERMAL HYPERSENSITIVITY AND RESISTANCE TO MUMPS.
    Enders JF; Kane LW; Maris EP; Stokes J
    J Exp Med; 1946 Sep; 84(4):341-64. PubMed ID: 19871574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against epidemic parotitis].
    Midulla M; Chiavelli S
    Pediatr Med Chir; 1984; 6(1):25-30. PubMed ID: 6442412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of mumps vaccines and immunization of monkeys against experimental mumps infection.
    HABEL K
    Public Health Rep (1896); 1946 Nov; 61(46):1655-64. PubMed ID: 20341095
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation of mumps virus from human beings with induced apparent or inapparent infections.
    HENLE G; HENLE W
    J Exp Med; 1948 Aug; 88(2):223-32. PubMed ID: 18873870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene.
    Yamada A; Takeuchi K; Tanabayashi K; Hishiyama M; Takahashi Y; Sugiura A
    Vaccine; 1990 Dec; 8(6):553-7. PubMed ID: 2087876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses detected among sporadic cases of parotitis, United States, 2009-2011.
    Barskey AE; Juieng P; Whitaker BL; Erdman DD; Oberste MS; Chern SW; Schmid DS; Radford KW; McNall RJ; Rota PA; Hickman CJ; Bellini WJ; Wallace GS
    J Infect Dis; 2013 Dec; 208(12):1979-86. PubMed ID: 23935203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral etiology of sporadic cases of parotitis among children in Korea during 2013-2014.
    Kang HJ; Kim SH; Chung JK; Lee SW; Choi SB; Eom HE; Park O; Kim K; Kim SS
    J Med Virol; 2018 Jan; 90(1):61-66. PubMed ID: 28876460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of the L-Zagreb mumps vaccine virus, Croatia, 2005-2008.
    Kaic B; Gjenero-Margan I; Aleraj B; Ljubin-Sternak S; Vilibic-Cavlek T; Kilvain S; Pavic I; Stojanovic D; Ilic A
    Euro Surveill; 2008 Apr; 13(16):. PubMed ID: 18768116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of virulence with retention of antigenicity of mumps virus after passage in the embryonated egg.
    ENDERS JF; LEVENS JH
    J Immunol; 1946 Nov; 54(3):283-91. PubMed ID: 21001446
    [No Abstract]   [Full Text] [Related]  

  • 16. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
    Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
    Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two patients with mumps].
    van Brummelen SE; de Vries E; Schneeberger PM; van Binnendijk RS; Lestrade P; Wever PC
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1732-5. PubMed ID: 16924947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mumps virus pathogenesis: Insights and knowledge gaps.
    Gouma S; Koopmans MP; van Binnendijk RS
    Hum Vaccin Immunother; 2016 Dec; 12(12):3110-3112. PubMed ID: 27455055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin as substrate of enzyme action by viruses of the mumps influenza group.
    BURNET FM; McCREA JF; ANDERSON SG
    Nature; 1947 Sep; 160(4064):404. PubMed ID: 20344692
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G.
    Narita M; Matsuzono Y; Takekoshi Y; Yamada S; Itakura O; Kubota M; Kikuta H; Togashi T
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):799-803. PubMed ID: 9801337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.